Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [18F]SiTATE PET
Main Authors: | Carmen Wängler, Leonie Beyer, Peter Bartenstein, Björn Wängler, Ralf Schirrmacher, Simon Lindner |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-09-01
|
Series: | EJNMMI Radiopharmacy and Chemistry |
Online Access: | https://doi.org/10.1186/s41181-022-00176-x |
Similar Items
-
Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE
by: Ralf S. Eschbach, et al.
Published: (2023-01-01) -
<i>LXX-Sitate</i> in die Petrus- en Paulusredes van Handelinge
by: G.J. Steyn
Published: (1995-09-01) -
Good practices for the automated production of 18F-SiFA radiopharmaceuticals
by: Simon Blok, et al.
Published: (2023-10-01) -
Lattices in Tate modules
by: Poonen, Bjorn, et al.
Published: (2022) -
Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) <sup>18</sup>F-Radiopharmaceuticals
by: Lexi Gower-Fry, et al.
Published: (2021-07-01)